Back
C4 Therapeutics Stock Predictions
Disrupting a Trillion-Dollar Industry
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
10
CCCC
C4 Therapeutics
Last Price:
$1.37
Seasonality Move:
23.04%
7 Day Trial
ALL ACCESS PASS
$
7
Your Portfolio's Boring. This Company Isn't And It's Early
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatioC4 Therapeutics Stock Forecast
-
Is C4 Therapeutics Stock Undervalued?The current C4 Therapeutics [CCCC] share price is $1.38. The Score for CCCC is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
-
CCCC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will C4 Therapeutics Stock Go Up Next Year?
Data Unavailable
C4 Therapeutics Stock Rating
Data Unavailable
C4 Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
c4therapeutics.com
52-Week Data
52-Week High:
7.66
52-Week Low:
1.09
Prediction Charts
Market Cap:
98M
Price in USD:
1.38
Volume:
453.4K
Beta:
3.12
Technical Analysis
SMA50:
1.57
SMA100:
2.43
SMA200:
3.96
52-Wk Change:
-75.22%
Stock Predictions
-
Is C4 Therapeutics stock public?Yes, C4 Therapeutics is a publicly traded company.
-
What is the C4 Therapeutics stock quote today?The C4 Therapeutics stock price is 1.38 USD today.
-
How to buy C4 Therapeutics stock online?You can buy C4 Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-6 | 1.59 | 1.41 | 1.59 | 1.40 |
| May-7 | 1.56 | 1.50 | 1.69 | 1.46 |
| May-8 | 1.53 | 1.54 | 1.61 | 1.42 |
| May-9 | 1.53 | 1.47 | 1.63 | 1.45 |
| May-12 | 1.52 | 1.58 | 1.64 | 1.52 |
| May-13 | 1.62 | 1.50 | 1.62 | 1.47 |
| May-14 | 1.49 | 1.37 | 1.50 | 1.36 |
| May-15 | 1.37 | 1.38 | 1.39 | 1.30 |
| May-16 | 1.39 | 1.38 | 1.42 | 1.34 |
| May-19 | 1.34 | 1.54 | 1.58 | 1.34 |
| May-20 | 1.52 | 1.48 | 1.54 | 1.45 |
| May-21 | 1.46 | 1.36 | 1.48 | 1.33 |
| May-22 | 1.39 | 1.37 | 1.42 | 1.35 |
| May-23 | 1.36 | 1.38 | 1.38 | 1.32 |
C4 Therapeutics Earnings
Data Unavailable
C4 Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.33 per share, and an increase next year of $0.06 per share.
* C4 Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.